The intersection of amyloid β and tau in glutamatergic synaptic dysfunction and collapse in Alzheimer's disease - PubMed (original) (raw)
Review
The intersection of amyloid β and tau in glutamatergic synaptic dysfunction and collapse in Alzheimer's disease
Johanna L Crimins et al. Ageing Res Rev. 2013 Jun.
Abstract
The synaptic connections that form between neurons during development remain plastic and able to adapt throughout the lifespan, enabling learning and memory. However, during aging and in particular in neurodegenerative diseases, synapses become dysfunctional and degenerate, contributing to dementia. In the case of Alzheimer's disease (AD), synapse loss is the strongest pathological correlate of cognitive decline, indicating that synaptic degeneration plays a central role in dementia. Over the past decade, strong evidence has emerged that oligomeric forms of amyloid beta, the protein that accumulates in senile plaques in the AD brain, contribute to degeneration of synaptic structure and function. More recent data indicate that pathological forms of tau protein, which accumulate in neurofibrillary tangles in the AD brain, also cause synaptic dysfunction and loss. In this review, we will present the case that soluble forms of both amyloid beta and tau protein act at the synapse to cause neural network dysfunction, and further that these two pathological proteins may act in concert to cause synaptic pathology. These data may have wide-ranging implications for the targeting of soluble pathological proteins in neurodegenerative diseases to prevent or reverse cognitive decline.
Keywords: Alzheimer; Amyloid beta; Synapse; Tau.
Copyright © 2013 Elsevier B.V. All rights reserved.
Figures
Figure 1
Alzheimer’s disease pathology. AD patient brains are characterized by gross atrophy of the hippocampus (arrow in A) and cortical thinning (arrowhead in A). Microscopically, the disease is defined by the presence of amyloid plaques (arrow in B) and neurofibrillary tangles (arrowhead in B). Plaques and tangles are both labeled by histological amyloid binding dyes such as thioflavin S shown here in panel B. Scale bars 1cm in A, 20 μm in B.
Figure 2
Model of synaptic effects of soluble tau in the rTg4510 model of tauopathy. In early tauopathy, dendritic architecture is preserved (1). Pathological soluble tau impairs microtubule-dependent transport in axons, which begin to die back distally (2), and in dendrites, where HCN channels subsequently insert into proximal dendritic and/or somatic membranes (3). The mislocalization and high density of HCN leads to an increased amplitude depolarizing sag potential at the soma (4), which contributes to significant depolarization of the resting membrane potential and associated increased action potential firing rates (5). Impaired trafficking to presynaptic sites may lead to a reduction and/or perturbation(s) in presynaptic vesicles (6a), whereas mislocalization of pathological soluble tau to spines (6b) and global disturbances in postsynaptic targeting, anchoring and/or turnover of glutamate receptors leads to a reduced density of postsynaptic AMPA receptors (6c). Excitatory synaptic transmission is disrupted, resulting in a higher proportion of low-amplitude sEPSCs (6d). In advanced tauopathy, some neurons possess intact apical dendritic tufts (7) due to distinctive initiation and progression of tau pathology, and/or patterns of deafferentation. The apical dendritic tuft is severely atrophic or is completely lost in many neurons; trans-synaptic transmission of tau pathology may contribute to this regressive process (8). Since approximately half of frontal cortical pyramidal neurons are lost, in part due to death cascades initiated by excitotoxicity (9), and remaining axons continue to regress (10), surviving neurons are deafferented. Spines density is decreased due to a specific reduction in mushroom spines and compensatory sprouting of filopodia and axonal boutons results in the formation new, albeit smaller excitatory synapses (11); these small synapses may account for the higher proportion of low-amplitude sEPSCs exhibited by some neurons (12). Many neurons with intact apical tufts demonstrate proliferative sprouting of oblique dendrites of the apical trunk (13) and may have increased numbers of shaft synapses (dashed box); these changes are consistent with an increased mean amplitude and proportion of high-amplitude sEPSCs (14). Compensatory responses (e.g. 11 and 13), in addition to further increased action potential firing rates, allow for relatively stable network function and preservation of some frontal lobe function (15).
Similar articles
- The intersection of amyloid beta and tau at synapses in Alzheimer's disease.
Spires-Jones TL, Hyman BT. Spires-Jones TL, et al. Neuron. 2014 May 21;82(4):756-71. doi: 10.1016/j.neuron.2014.05.004. Neuron. 2014. PMID: 24853936 Free PMC article. Review. - Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer's Disease.
Torres AK, Jara C, Park-Kang HS, Polanco CM, Tapia D, Alarcón F, de la Peña A, Llanquinao J, Vargas-Mardones G, Indo JA, Inestrosa NC, Tapia-Rojas C. Torres AK, et al. J Alzheimers Dis. 2021;84(4):1391-1414. doi: 10.3233/JAD-215139. J Alzheimers Dis. 2021. PMID: 34719499 Review. - A role for tau at the synapse in Alzheimer's disease pathogenesis.
Pooler AM, Noble W, Hanger DP. Pooler AM, et al. Neuropharmacology. 2014 Jan;76 Pt A:1-8. doi: 10.1016/j.neuropharm.2013.09.018. Epub 2013 Sep 25. Neuropharmacology. 2014. PMID: 24076336 Review. - Human tau increases amyloid β plaque size but not amyloid β-mediated synapse loss in a novel mouse model of Alzheimer's disease.
Jackson RJ, Rudinskiy N, Herrmann AG, Croft S, Kim JM, Petrova V, Ramos-Rodriguez JJ, Pitstick R, Wegmann S, Garcia-Alloza M, Carlson GA, Hyman BT, Spires-Jones TL. Jackson RJ, et al. Eur J Neurosci. 2016 Dec;44(12):3056-3066. doi: 10.1111/ejn.13442. Epub 2016 Nov 12. Eur J Neurosci. 2016. PMID: 27748574 Free PMC article. - The Role of Amyloid-Beta and Tau in the Early Pathogenesis of Alzheimer's Disease.
Yin X, Qiu Y, Zhao C, Zhou Z, Bao J, Qian W. Yin X, et al. Med Sci Monit. 2021 Sep 2;27:e933084. doi: 10.12659/MSM.933084. Med Sci Monit. 2021. PMID: 34471085 Free PMC article. Review.
Cited by
- A TrkB and TrkC partial agonist restores deficits in synaptic function and promotes activity-dependent synaptic and microglial transcriptomic changes in a late-stage Alzheimer's mouse model.
Latif-Hernandez A, Yang T, Butler RR 3rd, Losada PM, Minhas PS, White H, Tran KC, Liu H, Simmons DA, Langness V, Andreasson KI, Wyss-Coray T, Longo FM. Latif-Hernandez A, et al. Alzheimers Dement. 2024 Jul;20(7):4434-4460. doi: 10.1002/alz.13857. Epub 2024 May 23. Alzheimers Dement. 2024. PMID: 38779814 Free PMC article. - Synaptic alterations associated with disrupted sensory encoding in a mouse model of tauopathy.
Meftah S, Cavallini A, Murray TK, Jankowski L, Bose S, Ashby MC, Brown JT, Witton J. Meftah S, et al. Brain Commun. 2024 Apr 15;6(3):fcae134. doi: 10.1093/braincomms/fcae134. eCollection 2024. Brain Commun. 2024. PMID: 38712321 Free PMC article. - Tau pathology is associated with synaptic density and longitudinal synaptic loss in Alzheimer's disease.
Wang J, Huang Q, Chen X, You Z, He K, Guo Q, Huang Y, Yang Y, Lin Z, Guo T, Zhao J, Guan Y, Li B, Xie F. Wang J, et al. Mol Psychiatry. 2024 Apr 8. doi: 10.1038/s41380-024-02501-z. Online ahead of print. Mol Psychiatry. 2024. PMID: 38589563 - Alzheimer's disease as a synaptopathy: Evidence for dysfunction of synapses during disease progression.
Meftah S, Gan J. Meftah S, et al. Front Synaptic Neurosci. 2023 Mar 9;15:1129036. doi: 10.3389/fnsyn.2023.1129036. eCollection 2023. Front Synaptic Neurosci. 2023. PMID: 36970154 Free PMC article. Review. - Nanoparticulate air pollution disrupts proteostasis in Caenorhabditis elegans.
Garcia Manriquez BA, Papapanagiotou JA, Strysick CA, Green EH, Kikis EA. Garcia Manriquez BA, et al. PLoS One. 2023 Feb 23;18(2):e0275137. doi: 10.1371/journal.pone.0275137. eCollection 2023. PLoS One. 2023. PMID: 36821635 Free PMC article.
References
- Alonso AD, Grundke-Iqbal I, Barra HS, Iqbal K. Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: sequestration of microtubule-associated proteins 1 and 2 and the disassembly of microtubules by the abnormal tau. Proc Natl Acad Sci U S A. 1997;94:298–303. - PMC - PubMed
- Alzheimer A. Ubereine eigenartige Erkrankung der Hirnrinde. Allgemeine Zeitschrift fur Psychiatrie und Psychisch-Gerichtliche Medizin. 1907;64:146–148.
- Arendt T. Synaptic degeneration in Alzheimer’s disease. Acta Neuropathol. 2009;118:167–179. - PubMed
- Association, A.s. Alzheimer’s disease facts and figures. 2012. - PubMed
- Balietti M, Giorgetti B, Casoli T, Solazzi M, Tamagnini F, Burattini C, Aicardi G, Fattoretti P. Early Selective Vulnerability of Synapses and Synaptic Mitochondria in the Hippocampal CA1 Region of the Tg2576 Mouse Model of Alzheimer’s Disease. Journal of Alzheimer’s disease: JAD 2013 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous